The responsible pharmacist, in consultation with the health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19.713.6, Annotated Code of Maryland, shall develop, maintain, and review annually a quality assurance program regarding the automated medication system that addresses, at minimum: A testing program which includes daily accuracy sampling that verifies the integrity of the system; Investigation of medication errors related to the automated medication system, and remedial actions taken; Review of discrepancies and transaction reports to identify patterns of inappropriate use and access; Review of the overall functioning of the system2; Security and access: Preventative maintenance; Sanitation; Storage conditions; Inventory of drugs; Drug procurement, delivery, and receipt; Record keeping; Proper labeling procedures; and Protocols in the event of a power outage or other situation in which the services of the system are interrupted, that include: A plan for insuring continuity of pharmacy services to patients; and A plan for system recovery. The responsible pharmacist, in consultation with the health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19.713.6, Annotated Code of Maryland, shall develop, maintain, and review annually a quality assurance program regarding the remote or decentralized automated medication system that addresses, at a minimum, system override management to include: A list of medications that can be overridden which is limited to starter doses; and Review of system overrides to ensure appropriate utilization.